Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics
The blood-brain barrier (BBB), while being the gatekeeper of the central nervous system (CNS), is a bottleneck for the treatment of neurological diseases. Unfortunately, most of the biologicals do not reach their brain targets in sufficient quantities. The antibody targeting of receptor-mediated tra...
Saved in:
Main Authors: | Laura Rué (Author), Tom Jaspers (Author), Isabelle M. S. Degors (Author), Sam Noppen (Author), Dominique Schols (Author), Bart De Strooper (Author), Maarten Dewilde (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Agonistic nanobodies and antibodies to human VISTA
by: Yu-Heng Vivian Ma, et al.
Published: (2021) -
Research progress and applications of nanobody in human infectious diseases
by: Yaxian Mei, et al.
Published: (2022) -
Non-Human Primate Blood-Brain Barrier and In Vitro Brain Endothelium: From Transcriptome to the Establishment of a New Model
by: Catarina Chaves, et al.
Published: (2020) -
Nanobody
Published: (2021) -
An RNA Alternative to Human Transferrin: A New Tool for Targeting Human Cells
Published: (2013)